A 2-stage, Phase III Study To Investigate The Efficacy And Safety Of Anifrolumab In Adults With Chronic And/or Subacute Cutaneous Lupus Erythematosus (LAVENDER)
Scottsdale/Phoenix, AZ; Rochester, MN
This study aims to evaluate the efficacy and safety of subcutaneous (SC) anifrolumab versus placebo in adult participants with cutaneous lupus erythematosus (CLE).